Melatonin is synthesized in retinal photoreceptor cells and acts as a neuromodulator imparting photoperiodic information to the retina. The synthesis of melatonin is controlled by an ocular circadian clock and by light in a finely tuned mechanism that ensures that melatonin is synthesized and acts only at night in darkness. Here we report that the circadian clock gates melatonin synthesis in part by regulating the expression of the type 1 adenylyl cyclase (AC1) and the synthesis of cAMP in photoreceptor cells. This gating is effected through E-box-mediated transcriptional activation of the AC1 gene, which undergoes robust daily fluctuations that persist in constant illumination. The circadian control of the cAMP signaling cascade indicates that the clock has a more general and profound impact on retinal functions than previously thought. In addition, rhythmic control of AC1 expression was observed in other parts of the central circadian axis, the suprachiasmatic nucleus and pineal gland, but not in other brain areas examined. Thus, clock control of the cAMP signaling cascade may play a central role in the integration of circadian signals that control physiology and behavior.
Introduction
Circadian clocks are a conserved physiological feature of almost all organisms in which they play an important adaptive role. Retinal neurons of vertebrates, particularly photoreceptor cells, contain autonomous circadian clocks (Cahill and Besharse, 1993; Pierce et al., 1993; Menaker 1996, 1998 ) that have been implicated in the regulation of several retinal functions from gene expression to visual sensitivity (for review, see Cahill and Besharse, 1995; Anderson and Green, 2000; Tosini and Fukuhara, 2002) . Perhaps the most intensely investigated of these functions is melatonin biosynthesis, the synthesis of which in retinal photoreceptor cells displays a clear circadian rhythm in vivo and in vitro Cahill and Besharse 1993; Menaker, 1996, 1998) . Retinal melatonin is high at night and low during the day, and the changes in melatonin levels are a direct reflection of the change in the rate of transcription and activity of the enzyme arylalkylamine N-acetyltransferase (AA-NAT) Niki et al., 1998; Sakamoto and Ishida, 1998; Fukuhara et al., 2001) .
AA-NAT is a key regulatory enzyme in the melatonin biosynthetic pathway . In retina, AA-NAT is expressed primarily in photoreceptor cells Niki et al., 1998; Liu et al., 2004) . The promoter region of the rat AA-NAT gene contains a cAMP-responsive element (CRE) and an E-box (Chen and Baler, 2000) . Thus, the transcription of this gene might be regulated by changes in cAMP levels, which in photoreceptor cells follow changes in illumination (for review, see Iuvone 1995) , or directly by the circadian clock. Indeed, recent work has demonstrated that cAMP stimulates AA-NAT transcription and enzyme activity in photoreceptor cells Greve et al., 1999; Chen and Baler, 2000; Ivanova and Iuvone, 2003) . In addition, photoreceptor AA-NAT transcription is under direct control of the circadian clock via the action of the CLOCK:BMAL1 protein complex on the E-box contained in the proximal promoter of the gene (Chen and Baler, 2000; Tosini and Fukuhara, 2002) . These dual mechanisms for regulating melatonin biosynthesis in the retina present an ideal model for investigating the interactions between changes in environmental light and the circadian clock.
In the present report, we investigated the time-of-daydependent effects of darkness, which increases photoreceptor cAMP levels (for review, see Iuvone, 1995) , on retinal melatonin synthesis. Our results indicate the presence of a circadian mechanism that gates melatonin synthesis through transcriptional regulation of the type 1 adenylyl cyclase (AC1) by the BMAL1: CLOCK complex.
Materials and Methods
Animals and tissue collection. Adult male Sprague Dawley rats bred at Morehouse School of Medicine were maintained on a 12 hr light/dark (LD) cycle of illumination with light on from Zeitgeber time (ZT) 0 -12 for a least 1 week before experiments were performed. To investigate the expression in LD cycles, animals were killed at ZT 0, 4, 8, 12, 16, and 20 . When animals were killed during the night, the procedure was performed in dim red light (Ͻ0.1 lux). To investigate the pattern of expression in constant conditions, rats were transferred into constant dim red light (Ͻ0.1 lux) for 3 d before they were killed. In our experimental conditions, the free-running period was ϳ24.1 hr (our unpublished observation), and the phase shift on the fourth day was calculated to be negligible (Ͻ35 min); therefore, no adjustment was made to the sampling schedule. Samples were collected on the fourth day at circadian time (CT) 0, 4, 8, 12, 16, and 20 . Retinas were dissected, immediately frozen on dry ice, and stored at Ϫ80°C. For measurement of AC1 expression in the brain, animals were killed at ZT 8 and ZT 20, brains were removed and dissected, and the anatomical regions of interest were immediately frozen on dry ice and stored at Ϫ80°C.
Flow-through culture. Details about the flow-through culture technique and validation of melatonin radioimmunoassay are reported in previous studies Menaker, 1996, 1998) . In brief, the eyes were removed from the animals under halothane anesthesia during the daytime. Neural retinas were isolated and placed in the flow-through apparatus. Retinas were then cultured at 33°C (flow rate 1 ml/hr) in LD using medium 199 with Eagle's salts and L-glutamine supplemented with antibiotics (100 U/ml penicillin, 0.01 gm/ml streptomycin) and 10 M serotonin. On the second day of culture beginning at ZT 0, 3, 6, 9, or 12, retinas were exposed to darkness for 6 hr, and samples of perfusate were collected at 3 hr intervals.
Melatonin assay. The amount of melatonin in the culture medium was measured by radioimmunoassay, using a modification Menaker, 1996, 1998) of the method of Rollag and Niswender (1976) . The assay was validated with the following experiments. Melatonin (0, 10, 25, 50, 100, 200 pg per tube; four replicates at each level) was added to pooled retinal perfusates collected at night. The exogenous melatonin was recovered quantitatively (linear regression Y ϭ 0.95 ϫ ϩ81.02; r ϭ 0.99; p Ͻ 0.001; Y-intercept, 81.02 pg, represents the endogenous concentration of melatonin in the sample of retinal perfusate). A dilution curve of retinal perfusate was constructed and found to be parallel to that of melatonin standards, indicative of equivalent binding of the melatonin antibody in unknowns and standards (ANOVA; p Ͼ 0.01). The lower and upper limits of the radioimmunoassay sensitivity were 2.5 and 500 pg per tube, respectively. In addition, we performed chloroform extractions of samples of medium collected during the day and during the night, and in both cases the extraction efficiency was ϳ89%. Because this procedure eliminates the only compounds other than melatonin known to have significant cross-reactivity with the antibody (Rollag and Niswender, 1976) , this result makes it unlikely that we are measuring a substance other than melatonin. Because the procedure described above is not a complete validation, however, "melatonin" is used in this report as an abbreviation for "melatonin-like immunoreactivity." cAMP measurement. Retinas were homogenized in 6% TCA and centrifuged. Supernatant fractions were extracted repeatedly with ethyl ether, dried under nitrogen, and reconstituted in sodium acetate buffer, pH 6.2. cAMP levels were measured by radioimmunoassay (DuPont NEN, Boston, MA).
Real-time quantitative RT-PCR. Total RNA was extracted using Trizol (Life Technologies, Grand Island, NY) reagent after sonication. DNA was degraded by DNase I. First-strand cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase and according to the manufacturer's protocol. Each set of samples was simultaneously processed for RNA extraction, DNase I treatment, cDNA synthesis, and PCR reaction. Real-time quantitative PCR was performed using an iCycler (Bio-Rad, Hercules, CA) in the presence of SYBR green I with primers to rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (GenBank accession number X02231; 5Ј-AGACAGCCGCATCTTCTTGT-3Ј, 5Ј-TGATGGAACAATGTCCACT-3Ј) and rat adenylyl cyclase type I (AF053980; 5Ј-TAGCTCAAGGCTGTGTGGTG-3Ј, 5Ј-ACTGAG-CTCCAGGACAAGGA-3Ј). Amplification was performed after 30 sec of denaturation at 95°C. Once the temperature reached 95°C, it was decreased to 60°C, maintained for 20 sec, and raised to 72°C for 30 sec. Fluorescence was measured at the melting temperature after each cycle, allowing comparison of fluorescence intensities among samples while their increase is within the linear range. Quantification of AC1 and GAPDH cDNAs was accomplished by comparing the threshold cycles for amplification of the unknowns with those of four concentrations of AC1 and GAPDH standards using the iCycler software. Melting temperatures used were as follows: GAPDH, 86°C; AC1, 89°C. After 40 cycles of reactions, the PCR products were run on an agarose gel to verify that a single amplicon of appropriate size was amplified. AC1 mRNA levels were normalized using GAPDH mRNA levels. In each experimental set, the maximum value was set to 100, and each value was normalized relative to that maximum value .
Laser capture microdissection of photoreceptor cells. Whole eyes were embedded in OCT (Tissue-Tek, Torrance, CA), frozen on dry ice, and stored at Ϫ80°C. Frozen tissues were cut at 8 m thickness and mounted on uncharged glass slides (VWR Scientific). The frozen sections were thawed for 30 sec and fixed in 75% ethanol for 30 sec followed by a wash in RNase-free water for 30 sec. The sections were stained with HistoGene (Arcturus Engineering, Mountain View, CA) staining solutions for 15 sec followed by a wash with RNase-free water for 30 sec. The sections were dehydrated in graded ethanol solutions (75%, 30 sec; 95%, 30 sec; 100%, 30 sec) and cleared in xylene (5 min). After air-drying for 30 min, the slides were kept in a vacuum desiccator for a minimum of 2 hr. Laser capture was performed by lifting the outer nuclear layer and inner segments of photoreceptor cells onto HS-CapSure non-contact laser capture microdissection (LCM) film using a PixCell IIe LCM system (Arcturus Engineering). Total RNA was extracted from the captured cells using the PicoPure RNA Isolation Kit (Arcturus Engineering). Samples were reverse transcribed and subjected to real-time PCR analysis as described above.
Immunocytochemistry. Eyes, obtained from animals killed at ZT8 and ZT 20, were punctured and then fixed with 4% paraformaldehyde in PBS, pH 7.4, for 6 hr at 4°C. The eyes were then transferred to a solution of 30% sucrose for 24 hr at 4°C, embedded in Tissue-Tek OCT compound (Miles, Elkhart, IN) , and cut into 15-to 20-m-thick cryosections. Sections were then mounted on SuperFrost/plus slides (Fisher Scientific, Houston, TX). After three 10 min washes in PBS and 30 min incubation at room temperature in PBS containing 0.6% H 2 O 2 to block endogenous peroxidase activity, the sections were incubated in PBS containing 10% goat serum and 0.3% Triton X-100 for 20 min at room temperature to reduce nonspecific binding. Subsequently, the section were incubated for 45 min at room temperature followed by overnight incubation at 4°C in PBS containing 2% goat serum and 2 g/ml of the rabbit polyclonal affinity-purified antibody for AC1 (sc-586, polyclonal antibody; Santa Cruz Biotechnology, Santa Cruz, CA). This amount of primary antibody (2 g/ml) corresponds to a 1:50 dilution of the antibody solution provided. Sections were washed three times in PBS and incubated for 1 hr with the biotinylated secondary antibody (goat anti-rabbit IgG) at a 1:500 dilution in PBS containing 1% goat serum. The sections were washed (three times) for 10 min in PBS before the detection of immunolabeling with avidin-biotin-peroxidase, with H 2 O 2 and 3,3Ј-diaminobenzidine as substrate and nickel ammonium sulfate intensification (Vector Laboratories, Burlingame, CA). To determine the specificity of the antibody, negative controls were performed by omitting the primary antibody or by preabsorption with the blocking peptide (sc-586P) provided by Santa Cruz Biotechnology. Slides were coverslipped and viewed using a Zeiss Axioskop microscope.
Retinal cell culture. Isolated retinas were placed in DMEM and treated for 5 min in 0.025% trypsin with DNase (Worthington Biochemical Corporation, Lakewood, NJ) at 37°C. Retinas were triturated with glass fire-polished pipettes and added to an excess of culture medium consisting of DMEM with glutamine, 10% newborn calf serum (NCS), and antibiotics (100 U/ml penicillin, 100 g/ml streptomycin). The cells were centrifuged at 300 ϫ g for 4 min and then resuspended in fresh DMEM medium. Cells were plated into polylysine-coated 12-well plates (Becton Dickinson, Bedford, MA) at a density of 7 ϫ 10 5 cells per well and supplemented with 0.8 ml of DMEM/8% NCS.
Transfection and luciferase reporter gene assay. On the second day of culture, the NCS was reduced to 1% for subsequent transfection. Effectene Transfection Reagent (Qiagen, Valencia, CA) with 0.3 g DNA and 2.4 l enhancer was added to each well of the 12-well plate Tosini and Fukuhara, 2002) . AC1 promoter-luciferase construct or AC1 Emut promoter-luciferase cloned in the pGL3-Basic Vector (Promega, Madison, WI) was cotransfected with either BMAL1 and CLOCK expression vectors (cloned in pCl-neo mammalian expression vector; Promega, Madison, WI) or empty vector. Cells were also cotransfected with Renilla luciferase(Promega), an internal control for transfection efficiency. Cells were harvested 24 hr after transfection. Mutation at the E-box was introduced using the QuickChange site-directed mutagenesis kit (Stratagene, Cedar Creek, TX) with the following primers: 5Ј-CGCCCAAGGGGCCAGTGACCTTGGGCACC-3Ј and 5Ј-GGTGC-CCAAGGTCACTGGCCCCTTGGGCG-3Ј. Details about AC1 promoter constructs have been described in a previous study (Chan et al., 2001) . Increased cAMP levels reduce AC1 promoter-luciferase activity (Chan et al., 2001 ), indicating a negative feedback regulation of promoter activity.
To inhibit the increase of cAMP levels, cells were treated with the adenylyl cyclase inhibitor SQ-22,536 (200 M) for 6 hr before harvest. At least three wells were used to obtain n ϭ 1, and at least three independent experiments were performed. Luciferase assay was performed using the Dual-Luciferase Assay System (Promega) and a Berthold luminometer by following manufacturers' protocols. Each Firefly relative luciferase unit (RLU) was normalized to the Renilla RLU and the mean value of the AC1 ϩneo group set to 1.
Results

Melatonin synthesis in the retina is gated by the circadian clock
Rat retinas were cultured in a flow-through apparatus in a 12 hr LD cycle. During the second day of culture, retinas were exposed to a 6 hr period of darkness beginning in the middle of the day (ZT 6). Melatonin levels began to increase 3 hr after the start of the dark exposure and reached a maximum after 6 hr ( Fig. 1 A) . Melatonin levels after 6 hr of darkness were not different from the levels measured in the middle of the night (t test; p Ͼ 0.1; data not shown). Previous studies have shown that induction of melatonin synthesis depends on activation of the cAMP signaling pathway, which stimulates the activity of the melatonin-synthesizing enzyme AA-NAT by transcriptional and posttranslational mechanisms Klein et al., 1997; Klein et al., 2002) . Indeed, when retinas were exposed to 6 hr of darkness with the culture medium containing different concentrations of RpcAMPS (a membrane-permeable protein kinase A (PKA) type II inhibitor), melatonin synthesis was inhibited in a dosedependent manner (Fig. 1 B) ( p Ͻ 0.001).
The ability to stimulate retinal melatonin biosynthesis with darkness is dependent on the time of day that the stimulus is applied. When retinas were exposed to darkness for 6 hr at different times of the day, induction of melatonin synthesis was observed with incubations ending at ZT 12, 15, and 18, but not at ZT 6 or 9 ( Fig. 1 A, 2) , demonstrating that the induction of melatonin synthesis in darkness is gated by the circadian clock.
Adenylyl cyclase serves as a gate for melatonin synthesis
When the retinas were exposed to 6 hr of darkness in the presence of 100 M of 8p-CPT-cAMP (a membrane-permeable cAMP analog), melatonin release was significantly increased at all times tested (ZT 6 to ZT 18; p Ͻ 0.01 in all cases) (Fig. 2) . The differential time-of-day-specific effects of darkness and 8p-CPTcAMP demonstrate that the mechanism(s) gating the synthesis of melatonin during the day is located upstream of PKA, possibly at the level of adenylyl cyclase. We decided, therefore, to determine whether forskolin (a direct activator of adenylyl cyclase) could induce melatonin synthesis in the morning at a time that was refractory to darkness but not to 8p-CPT-cAMP. Exposing cultured retinas to darkness from ZT 3 to ZT 9 in the presence of forskolin (50 M) and 3-isobutyl-1-methylthanine (IBMX) (100 M) failed to produce a significant change in melatonin levels (Fig. 3) . The ability of 8pCPT-cAMP, but not darkness and forskolin, to stimulate melatonin formation in the morning suggests that at this time of day AC may be underexpressed or inhibited relative to later in the day and that AC serves as a gate for melatonin synthesis.
In retinas exposed to light, 8pCPT-cAMP increased melatonin synthesis at all times of day tested (Fig. 4) . In contrast, forskolin (50 M) or a combination of forskolin and IBMX (100 M) induced melatonin synthesis in light-exposed retinas only at ZT 6 -12 and ZT 9 -15 (Fig. 4) . IBMX alone had no effect on melatonin synthesis of light-exposed retinas at any time of day, consistent with the known suppression of photoreceptor cAMP synthesis by light. Figure 1 . A, Effect of darkness in the middle of the day on melatonin levels. Retinas were cultured in the flow-through apparatus for 1 d on an LD cycle; on the second day, the retinas were exposed to complete darkness for 3-6 hr beginning at ZT 6. Melatonin levels began to increase after 3 hr of darkness and reached nighttime levels after 6 hr (t test; p Ͻ 0.01). B, Rp-cAMPS (a PKA type II inhibitor) inhibits dark-dependent melatonin synthesis. Medium 199 was supplemented with Rp-cAMPS 3 hr before exposure to darkness. The control and all drugtreated groups were incubated in darkness for 6 hr beginning at ZT 6. Rp-cAMPS inhibited the dark-induced melatonin synthesis in a dose-dependent manner ( p Ͻ 0.001). Data are expressed as mean Ϯ SEM in cultured retinas (n ϭ 5 in all groups). 
Adenylyl cyclase transcription and activity are under circadian control
There are several different forms of adenylyl cyclase in mammalian tissues (Xia and Storm, 1997) . One of these, AC1, is neural specific, activated by Ca 2ϩ and calmodulin (CaM), and highly expressed in photoreceptor cells (Xia et al., 1993) . The induction of retinal AA-NAT by darkness is Ca 2ϩ dependent, requires Ca 2ϩ influx through voltage-gated channels, and is stimulated by cAMP (Iuvone and Besharse, 1986a,b) . These observations suggest that a Ca 2ϩ /CaM-stimulated cyclase may play a critical role in AA-NAT regulation. Therefore, we investigated the expression pattern of AC1 in the rat retina in LD and constant dim light using quantitative real-time RT-PCR. AC1 mRNA levels showed a significant rhythm in both conditions (Kruskal-Wallis test; p Ͻ 0.05 in both cases). The mRNA peaked during the day, and the lowest levels were observed in the late night to early morning (Fig.   5A ). The changes in mRNA levels were reflected by a rhythm of cAMP content (Fig. 5B) , demonstrating that the activity of adenylyl cyclase is rhythmic in situ. In LD, cAMP levels were lowest in the midmorning, when darkness and forskolin have no effect on melatonin production; levels of the cyclic nucleotide increase progressively through the day, peaking in the late night. This rhythm of cAMP level is delayed by several hours relative to the rhythm of AC1 mRNA, which is consistent with the time needed for synthesis and processing of the membrane protein (Tzavara et al., 1996) .
To determine whether the rhythm of AC1 mRNA level occurs in photoreceptor cells, we examined the expression of mRNAs encoding AC1 and Aa-nat in photoreceptor somata and inner segments isolated by laser capture microdissection (Fig. 6) . Aanat mRNA levels in photoreceptor cells were low during the day- . AC1 mRNA (black squares) and cAMP (white squares) levels were measured using real-time quantitative RT-PCR and radioimmunoassay, respectively. AC1 mRNA abundance was rhythmic in LD ( p ϭ 0.037) and constant dim light ( p ϭ 0.028). cAMP levels were rhythmic in LD ( p Ͻ 0.001) and in constant dim light ( p ϭ 0.011). Data are expressed as mean Ϯ SEM in cultured retinas (n Ն 5 retinas per group for AC1 mRNA measurements; n ϭ 3 retinas per group for cAMP measurements). Figure 6 . Laser capture microdissection of individual cell layers of rat retina. Photomicrographs of a retinal section before ( A) and after ( B) the photoreceptors layer has been serially captured using LCM. Aa-nat and AC1 transcript levels in microdissected photoreceptor cells. Photoreceptor somata and inner segments were collected by LCM from 8 m frozen sections of retinas obtained at ZT 8 and ZT 20. Total RNA was extracted from the captured material and subjected to real-time RT-PCR for GAPDH, Aa-nat ( C), and AC1 ( D). n ϭ 4 per group. Aa-nat mRNA was significantly higher at ZT 20 than at ZT 8 ( p ϭ 0.029). AC1 transcript level was significantly higher at ZT 8 than at ZT 20 ( p ϭ 0.027; Mann-Whitney rank sum test).
time (ZT 8) and high at night (ZT 20), consistent with previous measurements on whole rat retina (Sakamoto et al., , 2002 . In contrast, the AC1 transcript level in photoreceptor cells was high at ZT 8 and essentially undetectable at ZT 20. This result demonstrates that the AC1 and Aa-nat genes are both rhythmically expressed in photoreceptor cells and supports a causal relationship between the circadian control of AC1 and the gating of melatonin biosynthesis.
Rhythmic AC1 immunoreactivity in the photoreceptors
A previous paper reported that AC1 immunoreactivity is not present in rat photoreceptors (Abdel-Majid et al., 2002) ; however, that study analyzed AC1 immunoreactivity during the daytime. We decided therefore to determine whether AC1 immunoreactivity varies with the time of day. Two time points (ZT 8 and ZT 20) were selected for analysis on the basis of the observation that cAMP levels are low at ZT 8 and high at ZT 20 (Fig. 5) . In addition, a previous study has described a long temporal delay between the peaks of AC1 transcript level and Ca 2ϩ /calmodulinstimulated adenylyl cyclase activity in rat pineal (Tzavara et al., 1996) ; transcript levels were high at midday and enzyme activity was high at night. Thus, on the basis of our measurements of AC1 mRNA levels in retina, we predicted that AC1 protein levels would be high at ZT 20 and low at ZT 8. Photoreceptor inner segments showed strong AC1 immunoreactivity at ZT 20 (Fig.  7 D, E) but not at ZT 8 (Fig. 7 A, B) . This labeling was abolished by preabsorption of the primary antibody with blocking peptide (Fig. 7C,F ) . AC1 immunoreactivity was also present in the inner nuclear layer and in the ganglion cell layer, but no difference in immunoreactivity between the two time points was observed ( Fig. 7 A, B and D 
, E).
AC1 transcription is controlled by BMAL1:CLOCK
Several lines of evidence indicate that E-boxes are an integral part of the cis-acting element driving the circadian transcription of clock-controlled genes (Jin et al., 1999; Chong et al., 2000; Ripperger et al., 2000) . A previous study identified an E-box (CACGTG) in the promoter region of the AC1 gene (Chan et al., 2001) , indicating that the circadian oscillator might directly control the transcription of this gene by the action of the BMAL1: CLOCK complex, which trans-activates E-boxes. To assess the transcriptional competence of the AC1 E-box, a rat AC1 promoter-luciferase reporter construct was transfected into cultured retinal cells with either empty (neo-) or BMAL1 and CLOCK expression vectors. As shown in Figure 8 , AC1 promoterluciferase activity was significantly increased by cotransfection of BMAL1 and CLOCK. More significantly, mutation of the E-box within the AC1 promoterluciferase reporter construct completely blocked reporter gene expression in retinal cells even when cotransfected with BMAL1 and CLOCK.
AC1 mRNA expression in other parts of the brain AC1 is neural specific and expressed only in specific areas of the brain such as neocortex, cerebellum, olfactory bulb, hippocampus, and pineal gland (Xia et al., 1993) . Therefore, we questioned whether AC1 transcription is under direct control of the circadian clock in these tissues, as well as in retina. As shown in Figure 9A -C, AC1 mRNA levels during the daytime (ZT 8) were not significantly different from those at night (ZT 20) in the hippocampus, cerebellum, and olfactory bulb. In contrast, AC1 transcript levels in the pineal gland and suprachiasmatic nucleus (SCN) show clear daily rhythms ( p Ͻ 0.05 and p Ͻ 0.01) (Fig. 9 D, E) . Because our study investigated AC1 mRNA at only two time points, no definitive conclusion can be reached regarding the absence of rhythmicity in neocortex, cerebellum, olfactory bulb, and hippocampus.
Discussion
Retinal melatonin levels are regulated by the interaction between the circadian clock and the photic environment. Several studies have demonstrated that the rhythm in melatonin release from cultured retinas free-runs in constant darkness, is entrainable by the light, and is temperature compensated Menaker, 1996, 1998) . The fact that this rhythm shows the three fundamental characteristics of a circadian clock (i.e., free-run, entrainment, and temperature compensation) demonstrates that melatonin synthesis in the retina is controlled by a bona fide circadian clock located within this tissue. In addition to clock control, retinal melatonin levels rapidly (5-10 min) decrease after light exposure at night (Hamm et al., 1983; Fukuhara et al., 2001) to ensure that melatonin is released and acts only in darkness. As in the pineal gland (Gastel et al., 1998) , the rapid reduction in melatonin levels is achieved by a rapid decrease in AA-NAT enzyme by proteasomal proteolysis (Fukuhara et al., 2001; Iuvone et al., 2002) .
The results presented here, as well as those of previous studies, have led to the following working hypothesis on the control of AA-NAT activity in photoreceptor cells by the circadian clock and light (Fig. 10) . The circadian clock directly controls the rhythmic expression of Aa-nat mRNA through the BMAL1: CLOCK complex and its interaction with the E-box located on the Aa-nat promoter. The circadian clock also provides for the rhythmic expression of AC1, temporally regulating the ability of Ca 2ϩ to stimulate cAMP synthesis. Darkness depolarizes the photoreceptor plasma membrane, leading to Ca 2ϩ influx and stimulation of cAMP synthesis late in the day and at night, when AC1 protein expression is high, but not during the early morning. Thus, AC1 expression provides a gate controlling the time of day when cAMP levels are maximally stimulated by darkness. The increase of cAMP level in darkness stimulates Aa-nat transcription via PKA and the CRE present in the Aa-nat promoter, increasing the rate of AA-NAT protein synthesis. In addition, the increase of cAMP and PKA activity phosphorylates and stabilizes AA-NAT, leading to its interaction with 14-3-3 proteins and inhibition of its degradation by proteasomes. Thus, melatonin synthesis is stimulated by darkness late in the day and at night, but not during the morning. Light exposure at night, which rapidly decreases melatonin synthesis, does so by hyperpolarizing the photoreceptor cell, leading to decreased intracellular Ca 2ϩ and cAMP levels and the dephosphorylation and degradation of AA-NAT. Although some aspects of this hypothesis remain untested, it is consistent with the present data and an extensive literature.
The effects of daytime exposure to darkness on retinal melatonin synthesis and release have been investigated, but the results obtained are contradictory. Redburn and Mitchell (1989) reported that exposure to darkness during the day induced (within 1 hr) rapid synthesis and releases of melatonin from the retina, whereas Faillace et al. (1994) found melatonin levels increased only after a much longer period (6 hr) of darkness. In the present study we investigated the effect of daytime exposure to darkness on melatonin synthesis and release in the rat retina at different times of the day. Our data demonstrate that exposing cultured rat retina to darkness can only activate melatonin synthesis in the middle to late day and at night (Fig. 2) . Darkness early in the day has no effect. The stimulation of melatonin synthesis that occurs in darkness is attributable to the activation of cAMP signaling cascade (Fig. 1 B) , as it is in retinas of non-mammalian vertebrates (Iuvone and Besharse, 1983, 1986a,b; Hasegawa and Cahill, 2000) .
The signaling pathway responsible for the activation of melatonin synthesis in chick retina has been partially elucidated (for review, see Iuvone et al., 1997 Iuvone et al., , 1999 . In this experimental model, depolarization of photoreceptors, as happens in darkness (Wer- Figure 8 . AC1 transcriptional regulation by BMAL1 and CLOCK. AC1 promoter-driven luciferase activity in retinal cultures was significantly increased by cotransfection of BMAL1 and CLOCK with respect to the activity obtained by cotransfecting with empty expression vector (t test; p Ͻ 0.01). AC1 mut luciferase construct (i.e., a construct in which the E-box has been mutated from CACGTG to CACTG) was not activated by cotransfecting with BMAL1 and CLOCK or with empty expression vector (t test; p Ͼ 0.1). Values are means Ϯ SEM (n ϭ 3 for each of the three independent experiments). blin and Dowling, 1969), induces AA-NAT activity by a Ca 2ϩ -and cAMP-dependent mechanism Gan et al., 1995; Ivanova and Iuvone, 2003) . Depolarization of the photoreceptor membrane opens dihydropyridine-sensitive voltagegated Ca 2ϩ channels, resulting in a large, sustained increase in intracellular Ca 2ϩ concentration in photoreceptor inner segments and the Ca 2ϩ -dependent stimulation of cAMP formation, apparently by activating calmodulin-stimulated adenylyl cyclase (Iuvone et al., 1991; Gan et al., 1995; Uchida and Iuvone, 1999) . The increase of intracellular cAMP activates AA-NAT gene transcription and decreases AA-NAT protein degradation, consequently stimulating AA-NAT activity and melatonin synthesis Alonso-Gomez and Iuvone, 1998; Gastel et al., 1998; Greve et al., 1999; Chen and Baler, 2000) .
In the present study we found that a cAMP analog, which activates PKA, elevates melatonin levels at all the times of the day (Fig. 2) , even in the morning when darkness is ineffective. This observation indicates that the mechanisms that gate darknessstimulated melatonin synthesis in the early part of the day must be located upstream of cAMP. The observation that forskolin treatment also failed to induce melatonin synthesis early in the day (Fig. 3) suggests that calmodulin-stimulated adenylyl cyclase activity may be low in the morning and a limiting factor in darkevoked melatonin biosynthesis.
The results of the experiment shown in Figure 4 demonstrate that cyclic nucleotide phosphodiesterase (PDE) activity is not involved in this phenomenon because IBMX (a specific PDE inhibitor) alone or in combination with forskolin does affect melatonin synthesis at ZT 0 -6 or ZT 3-9 (Fig. 4) . This result indicates that changes of cAMP synthesis rather than breakdown are important for gating melatonin synthesis at ZT 0 -6 or ZT 3-9. It must mentioned, however, that forskolin and IBMX may act synergistically to potentiate the effect of cAMP analog and forskolin at least at ZT 6 -12 and ZT 9 -12 (Fig. 4) , and such a result is in agreement with previous experimental observations (Gan et al., 1995) .
Gating by the circadian clock in retina has been observed previously in the retina and in the SCN (Ginty et al., 1993; Obrietan et al., 1999) , but these studies identified neither the location of the gate nor the mechanisms by which the circadian clock controls the gate. The present investigation demonstrates that cAMP levels and AC1 mRNA abundance show a clear circadian rhythm in retina (Fig. 5 ) and photoreceptor cells (Fig. 6) . These results are consistent with studies showing circadian control of cAMP levels in chick photoreceptors and pinealocytes (Nikaido and Takahashi, 1998; Ivanova and Iuvone, 2003) and of phospho-cAMP response element-binding protein levels in Xenopus photoreceptors (Liu and Green, 2002) , all of which are high at night.
A previous study has reported that in the rat retina AC1 mRNA is expressed predominantly in the photoreceptors (Xia et al., 1993) , whereas a recent immunohistochemical study failed to detect AC1 protein (or other calcium-sensitive adenylyl cyclase) in the photoreceptors (Abdel-Majid et al., 2002) . Our results (Fig.  7 A, B, D, E) demonstrate that AC1 protein is expressed in the photoreceptors, but it is detectable only during the night (Fig.  7 D, E) . The fact that AC1 protein levels are low during the day and high at night further supports our conclusion that melatonin synthesis cannot be induced by darkness and forskolin at ZT 0 and ZT 3 because cAMP synthesis is insufficient at these times.
The transcription of the clock-controlled gene can be activated by the circadian transcription factors BMAL1 and CLOCK, if the genes contain E-boxes in their promoters (Jin et al., 1999; Chong et al., 2000; Ripperger et al., 2000) , as do the Aa-nat and AC1 promoters (Chen and Baler, 2000; Chan et al., 2001) . Our study demonstrated that AC1 promoter activity is directly regulated by the clock via the action of the BMAL1:CLOCK complex and contributes to the circadian gating of melatonin synthesis in photoreceptor cells (Fig. 8) . Similarly, it was reported that Ca 2ϩ / calmodulin-stimulated adenylyl cyclase activity is regulated by a circadian clock in chicken pineal photoreceptors (Nikaido and Takahashi, 1998) .
The circadian rhythm of cAMP in retina, with a trough early in the day when neither darkness nor forskolin stimulates melatonin synthesis, strongly suggests that regulation of the cAMP level represents a gate controlling melatonin biosynthesis. The circadian expression of AC1 mRNA and protein in photoreceptors indicates that the cyclase contributes to gating of melatonin synthesis by the clock; however, it does not exclude the involvement of other Ca 2ϩ /calmodulin-stimulated or Ca 2ϩ -independent adenylyl cyclases or of cyclic nucleotide phosphodiesterases in the gating mechanism. These await further investigation.
A potential flaw in our hypothesis is that the Aa-nat and AC1 transcript rhythms are not in phase. AC1 mRNA peaks during the daytime, whereas Aa-nat transcript levels are highest at night. If rhythmic transcription is driven primarily by BMAL1:CLOCKmediated transactivation, the rhythms of expression of both genes might be expected to be synchronous; however, this temporal discrepancy may be attributable to the presence of other regulatory inputs to the two promoters. In particular, cAMP has opposite effects on the AC1 and Aa-nat promoters. cAMP inhibits AC1 promoter activity (Chan et al., 2001 ) but stimulates the Aa-nat promoter . The low level of cAMP during the daytime may be permissive for BMAL1:CLOCKmediated stimulation of AC1 transcription, leading to peak levels of AC1 mRNA during the daytime. Conversely, the high level of cAMP at night may enhance BMAL1:CLOCK-mediated Aa-nat transcription, which is highest at night.
Although cAMP does not appear to be directly involved in visual transduction, it regulates several aspects of photoreceptor metabolism linked to light and dark adaptation. For example, cAMP is involved in the regulation of membrane turnover in rod outer segments, cone retinomotor movement, the activity of the G ␤ ␥-binding protein phosducin, and melatonin biosynthesis, as well as some types of retinal degeneration and photoreceptor apoptosis (Besharse et al., 1982; Yoshida et al., 1994; Weiss et al., 1995; Fassina et al., 1997; Alfinito and Townes-Anderson, 2002) . The fact that the retinal circadian clock controls the cAMP signaling cascade indicates that this clock has a more general and profound impact on retinal functions than previously thought. In particular, it is important to note that the circadian clock gates the cAMP signaling cascade at the night-to-day transition when the photoreceptors need to rapidly adapt to changes in the levels of illumination.
In mammals, the central circadian pacemaker controlling the vast majority of circadian rhythms, including that of pineal melatonin biosynthesis, is located within the SCN of the hypothalamus (Klein et al., 1991) . CRE-mediated gene expression in the SCN shows circadian rhythmicity, and photic stimulation increases CRE-mediated transcription during the subjective night but not the subjective day (Obrietan et al., 1999) . Our results (Fig.  9) suggest that the circadian clock may gate the cAMP signaling cascade in the SCN, as it does in the retina and pineal gland. Thus, gating of cAMP signaling may play a key role in input and output components of the central circadian axis, the retina, the SCN, and the pineal gland.
